does blue cross blue shield cover glp-1 medication Anthem Wegovy for Weight Loss? Does Blue Cross Blue Shield

Food and Drug Administration (FDA) accelerated approval for treating metabolic dysfunction-associated steatohepatitis (MASH), the first GLP-1 approved for this indication Metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), is a serious condition that occurs when fat accumulates in the liver, causing inflammation and damage, such as scarring (fibrosis), cirrhosis or liver failure

regulators have begun taking steps to restrict compounded GLP-1 productsnon-FDA-approved versions of branded drugs produced by specialized pharmacies

Most show long-term benefits with manageable risks

It makes me feel rejuvenated and vital